White Papers / Tech Papers
Regulatory Considerations for Excipients Used in Lipid Nanoparticles
This whitepaper provides an overview on the regulatory classification and emerging regulatory challenges for LNP, liposomes, and novel excipients.
More White Papers / Tech Papers by MilliporeSigma
More Content From MilliporeSigma
-
Manufacturing Science and Technology Manager discusses M Lab Collaboration Centers and addressing customers pain points.
-
The ability to monitor biopharma processes in real time provides significant advantages in optimizing product quality with respect to multiple attributes.
-
MilliporeSigma unveils its new Mobius® iFlex Bioreactor family for fed-batch and perfusion upstream processes.
-
How do sponsors and CMOs realize the advantages of their partnership while avoiding the pitfalls of clunky data sharing?
-
This automated approach minimizes the number of human interventions needed and reduces the risk of contamination and batch failures.
-
The Pellicon® Capsule is the first of its kind—a true single-use TFF device that streamlines bioprocessing with its innovative, simplified design.
-
MilliporeSigma's new HPAPI contract manufacturing facility brings unmatched capacity to the market.
-
The accelerated pathway through the clinic of viral vector-based cell and gene therapies puts pressure on developers to find a skilled partner.
-
This white paper demonstrates the feasibility of novel virus spiking strategies to meet the needs of continuous processes.